Neurones SA
PAR:NRO
Neurones SA
PAR:NRO
Price:
44
EUR
-6.38%
Market Cap:
1.1B
EUR
Balance Sheet
Balance Sheet Decomposition
Neurones SA
Neurones SA
| Current Assets | 546.3m |
| Cash & Short-Term Investments | 264.2m |
| Receivables | 267m |
| Other Current Assets | 15.1m |
| Non-Current Assets | 133.1m |
| Long-Term Investments | 10.9m |
| PP&E | 60.2m |
| Intangibles | 55.6m |
| Other Non-Current Assets | 6.4m |
Balance Sheet
Neurones SA
Neurones SA
Currency: EUR
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
122
|
130
|
129
|
146
|
170
|
215
|
261
|
261
|
270
|
269
|
|
| Cash |
40
|
53
|
66
|
71
|
95
|
95
|
138
|
92
|
74
|
26
|
|
| Cash Equivalents |
82
|
77
|
63
|
75
|
75
|
120
|
123
|
170
|
195
|
243
|
|
| Short-Term Investments |
0
|
0
|
11
|
7
|
3
|
3
|
5
|
173
|
197
|
271
|
|
| Total Receivables |
128
|
149
|
173
|
186
|
202
|
186
|
176
|
190
|
225
|
236
|
|
| Accounts Receivables |
92
|
102
|
121
|
127
|
134
|
131
|
129
|
137
|
165
|
174
|
|
| Other Receivables |
36
|
47
|
52
|
59
|
68
|
55
|
46
|
53
|
60
|
63
|
|
| Inventory |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
1
|
|
| Other Current Assets |
3
|
4
|
5
|
6
|
8
|
8
|
7
|
9
|
10
|
12
|
|
| Total Current Assets |
254
|
284
|
319
|
346
|
383
|
413
|
449
|
464
|
507
|
546
|
|
| PP&E Net |
8
|
15
|
14
|
16
|
16
|
47
|
47
|
46
|
49
|
59
|
|
| PP&E Gross |
8
|
15
|
14
|
16
|
16
|
47
|
47
|
46
|
49
|
59
|
|
| Accumulated Depreciation |
19
|
23
|
27
|
31
|
37
|
50
|
61
|
70
|
59
|
96
|
|
| Intangible Assets |
0
|
2
|
2
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Goodwill |
36
|
38
|
43
|
41
|
40
|
40
|
43
|
45
|
45
|
52
|
|
| Long-Term Investments |
4
|
11
|
6
|
6
|
7
|
7
|
8
|
8
|
10
|
11
|
|
| Other Long-Term Assets |
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
5
|
6
|
|
| Other Assets |
36
|
38
|
43
|
41
|
40
|
40
|
43
|
45
|
45
|
52
|
|
| Total Assets |
304
N/A
|
351
+15%
|
386
+10%
|
412
+7%
|
449
+9%
|
510
+14%
|
550
+8%
|
568
+3%
|
616
+9%
|
674
+9%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
17
|
30
|
26
|
29
|
31
|
31
|
33
|
38
|
43
|
44
|
|
| Accrued Liabilities |
75
|
81
|
90
|
90
|
92
|
92
|
94
|
103
|
115
|
125
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
1
|
1
|
0
|
7
|
7
|
7
|
8
|
11
|
|
| Other Current Liabilities |
14
|
20
|
27
|
22
|
28
|
26
|
28
|
36
|
41
|
47
|
|
| Total Current Liabilities |
107
|
133
|
145
|
142
|
152
|
156
|
161
|
185
|
207
|
229
|
|
| Long-Term Debt |
0
|
2
|
1
|
0
|
0
|
25
|
27
|
28
|
27
|
31
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
16
|
17
|
21
|
25
|
29
|
30
|
36
|
41
|
45
|
54
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
6
|
6
|
|
| Total Liabilities |
124
N/A
|
153
+24%
|
169
+10%
|
169
+0%
|
182
+8%
|
213
+17%
|
227
+7%
|
256
+13%
|
286
+11%
|
320
+12%
|
|
| Equity | |||||||||||
| Common Stock |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|
| Retained Earnings |
140
|
157
|
176
|
202
|
226
|
256
|
282
|
270
|
289
|
313
|
|
| Additional Paid In Capital |
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
|
| Total Equity |
181
N/A
|
198
+10%
|
217
+9%
|
243
+12%
|
267
+10%
|
297
+11%
|
323
+9%
|
312
-3%
|
331
+6%
|
354
+7%
|
|
| Total Liabilities & Equity |
304
N/A
|
351
+15%
|
386
+10%
|
412
+7%
|
449
+9%
|
510
+14%
|
550
+8%
|
568
+3%
|
616
+9%
|
674
+9%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
